Matt Niederst

Matt Niederst

Novartis Institutes for BioMedical Research - Bhubaneswar / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4387025
-
person_outline Matt Niederst's MOST POPULAR ARTICLES
1-) Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibitionAN Hata, MJ Niederst, HL Archibald, M Gomez-Caraballo, FM Siddiqui, ...Nature medicine 22 (3), 262-269, 20167442016
2-) Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of originMG Oser, MJ Niederst, LV Sequist, JA EngelmanThe Lancet Oncology 16 (4), e165-e172, 20157392015
3-) Patient-derived models of acquired resistance can identify effective drug combinations for cancerAS Crystal, AT Shaw, LV Sequist, L Friboulet, MJ Niederst, EL Lockerman, ...Science 346 (6216), 1480-1486, 20147392014
4-) RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancerMJ Niederst, LV Sequist, JT Poirier, CH Mermel, EL Lockerman, ...Nature communications 6 (1), 6377, 20156072015
5-) The allelic context of the C797S mutation acquired upon treatment with third-generation EGFR inhibitors impacts sensitivity to subsequent treatment strategiesMJ Niederst, H Hu, HE Mulvey, EL Lockerman, AR Garcia, Z Piotrowska, ...Clinical Cancer Research 21 (17), 3924-3933, 20155762015